Summit Therapeutics Inc. (NASDAQ: SMMT) has announced its participation in the 47th Annual Goldman Sachs Global Healthcare Conference, scheduled for June 8, 2026, in Miami, Florida. The company’s management team will conduct a fireside chat presentation at 10:00 AM ET, where they will provide an overview of the company and updates on their investigational bispecific antibody, ivonescimab. This presentation aims to inform stakeholders about Summit's recent progress and strategic initiatives. Attendees can access the presentation live on Summit's website, with an archived version available afterward. Founded in 2003, Summit Therapeutics is a biopharmaceutical company dedicated to discovering and developing therapies that enhance the quality of life and address serious unmet medical needs. The company is headquartered in Miami, with additional offices in Palo Alto, California; Princeton, New Jersey; Dublin, Ireland; and Oxford, UK. Summit emphasizes that any forward-looking statements regarding its future plans and prospects are subject to various risks and uncertainties.